Progress for the privileged: Celebrating innovation, ignoring access
We celebrate breakthroughs in immunotherapy, gene-editing, and artificial intelligence in diagnosis. We rarely ask: for whom?
We celebrate breakthroughs in immunotherapy, gene-editing, and artificial intelligence in diagnosis. We rarely ask: for whom?